Pfizer and Bristol-Myers face three new lawsuits in New York claiming their big-selling anticoagulant Eliquis ended up hurting patients.

Two former Heritage Pharma execs will cooperate with a broad generic pricing probe that's roped in some of the biggest companies in the business.

The already embattled Valeant has no interest in footing the bill for liability lawsuits over the talc products it bought from J&J.

A shareholder is taking it to the company’s current and former execs for “gross mismanagement” and other allegations.

Merck & Co. and Upsher-Smith agreed to settle with drug purchasers that alleged the companies inked a deal to delay generic competition to Merck's K-…

A federal judge hearing the bellwether lawsuit for "low-T" drug marketing decided the plaintiff’s case was suffering from a lack of support for some…

A U.S. appeals court sided with Biogen in a lawsuit claiming execs weren't open with investors about Tecfidera's sales trajectory after the death of…

When Louisiana AG Jeff Landry inherited an antitrust lawsuit against Pfizer in 2015, he spotted an opportunity to combat the state’s opioid epidemic.

Legal